Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Z. Zafeiriou · SciRah

Researcher profile · Semantic Scholar

Z. Zafeiriou

Share profile

Z. Zafeiriou — researcher profile on SciRah

h-index: 26
Works: 69
Citations: 9,678

Most-cited papers

Integrative clinical genomics of advanced prostate cancer
D. Robinson, E. V. Van Allen, Yi-Mi Wu, N. Schultz +69 more
2015Cell3,286 citations Open access
Semantic Scholar
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo, S. Carreira, S. Sandhu, S. Miranda +47 more
2015New England Journal of Medicine2,015 citations Open access
Semantic Scholar
The long tail of oncogenic drivers in prostate cancer
J. Armenia, Stephanie A. M. Wankowicz, David Liu, Jian-Jiong Gao +35 more
2018Nature Genetics779 citations Open access
Semantic Scholar
Plasma AR and abiraterone-resistant prostate cancer
A. Romanel, Delila Gasi Tandefelt, V. Conteduca, A. Jayaram +19 more
2015Science Translational Medicine455 citations Open access
Semantic Scholar
Integrative Clinical Genomics of Advanced Prostate Cancer.
D. Robinson, E. V. Van Allen, Yi-Mi Wu, N. Schultz +69 more
2015Cell446 citations Open access
Semantic Scholar
Circulating Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
J. Goodall, J. Mateo, W. Yuan, H. Mossop +30 more
2017Cancer Discovery378 citations Open access
Semantic Scholar
Genomics of lethal prostate cancer at diagnosis and castration resistance
J. Mateo, G. Seed, C. Bertan, P. Rescigno +31 more
2019Journal of Clinical Investigation270 citations Open access
Semantic Scholar
PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate
R. Ferraldeschi, Daniel Nava Rodrigues, R. Riisnaes, S. Miranda +20 more
2015European Urology258 citations Open access
Semantic Scholar
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.
D. Lorente, J. Mateo, A. Templeton, Z. Zafeiriou +7 more
2015Annals of Oncology203 citations Open access
Semantic Scholar
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues, P. Rescigno, David Liu, W. Yuan +48 more
2018Journal of Clinical Investigation195 citations Open access
Semantic Scholar
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity
G. Boysen, D. Rodrigues, P. Rescigno, G. Seed +29 more
2018Clinical Cancer Research121 citations Open access
Semantic Scholar
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer
J. Welti, D. Rodrigues, A. Sharp, Shi-Hua Sun +7 more
2016European Urology117 citations Open access
Semantic Scholar
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
T. Shenoy, G. Boysen, M.-Y. Wang, Q.-Z. Xu +22 more
2017Annals of Oncology113 citations Open access
Semantic Scholar
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
M. Papadaki, G. Kallergi, Z. Zafeiriou, Lefteris Manouras +4 more
2014BMC Cancer108 citations Open access
Semantic Scholar
Diffusion-weighted imaging as a treatment response biomarker evaluating bone metastases in prostate cancer: a pilot study
R. Pérez-López, J. Mateo, H. Mossop, M. Blackledge +15 more
2016Radiology101 citations Open access
Semantic Scholar
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
M. Lambros, G. Seed, S. Sumanasuriya, V. Gil +32 more
2018Clinical Cancer Research96 citations Open access
Semantic Scholar
Switching and withdrawing hormonal agents for castration-resistant prostate cancer
D. Lorente, J. Mateo, Z. Zafeiriou, A. Smith +3 more
2015Nature reviews. Urology79 citations
Semantic Scholar
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
Z. Zafeiriou, D. Bianchini, R. Chandler, P. Rescigno +17 more
2019European Urology76 citations Open access
Semantic Scholar
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer
M. Kolinsky, P. Rescigno, D. Bianchini, Z. Zafeiriou +26 more
2020Annals of Oncology68 citations Open access
Semantic Scholar
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.
P. Rescigno, D. Lorente, D. Bianchini, R. Ferraldeschi +15 more
2016European Urology68 citations Open access
Semantic Scholar
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer
A. Mcdaniel, R. Ferraldeschi, R. Krupa, M. Landers +15 more
2016BJU International67 citations Open access
Semantic Scholar
First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome
Viktoria Christoforaki, Z. Zafeiriou, Georgios Daskalakis, T. Katasos +1 more
2019Journal of Obstetrics and Gynaecology Research53 citations
Semantic Scholar
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer
A. Voutsina, M. Tzardi, A. Kalikaki, Z. Zafeiriou +4 more
2013Modern Pathology53 citations Open access
Semantic Scholar
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
P. Rescigno, D. Lorente, D. Dolling, R. Ferraldeschi +14 more
2018European Urology Oncology41 citations Open access
Semantic Scholar
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
D. Lorente, A. Omlin, Z. Zafeiriou, D. Nava-Rodrigues +16 more
2016Clinical Genitourinary Cancer34 citations Open access
Semantic Scholar
External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone.
P. Ravi, J. Mateo, D. Lorente, Z. Zafeiriou +9 more
2014European Urology27 citations
Semantic Scholar
Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital
D. Bianchini, D. Lorente, P. Rescigno, Z. Zafeiriou +19 more
2017Clinical Genitourinary Cancer19 citations Open access
Semantic Scholar
LBA20ANTITUMOUR ACTIVITY OF THE PARP INHIBITOR OLAPARIB IN UNSELECTED SPORADIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC) IN THE TOPARP TRIAL
J. Mateo, E. Hall, S. Sandhu, A. Omlin +16 more
201418 citations Open access
Semantic Scholar
Cabozantinib-Getting Under the Skin of Cutaneous Toxicity.
A. Jayaram, Z. Zafeiriou, J. de Bono
2015JAMA Oncology13 citations Open access
Semantic Scholar
Publisher Correction: The long tail of oncogenic drivers in prostate cancer
J. Armenia, Stephanie A. M. Wankowicz, David Liu, Jian-Jiong Gao +35 more
2019Nature Genetics12 citations Open access
Semantic Scholar
Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS)
N. Mehra, G. Seed, M. Lambros, A. Sharp +15 more
201612 citations Open access
Semantic Scholar
CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer
N. Mehra, Z. Zafeiriou, D. Lorente, L. Terstappen +1 more
2015Clinical Cancer Research11 citations Open access
Semantic Scholar
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study
F. Koinis, Z. Zafeiriou, I. Messaritakis, P. Katsaounis +11 more
2023Cancers9 citations Open access
Semantic Scholar
Genetic Analysis of Circulating Tumour Cells.
M. Kolinsky, Nikolas H. Stoecklein, M. Lambros, V. Gil +4 more
2020Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer9 citations
Semantic Scholar
Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer
J. Mateo, S. Sandhu, S. Miranda, S. Carreira +30 more
20159 citations
Semantic Scholar
Abstract P1-04-08: Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
M. Papadaki, S. Agelaki, G. Kallergi, Z. Zafeiriou +3 more
20139 citations
Semantic Scholar
First trimester neutrophil-to-lymphocyte ratio (NLR) and pregnancy outcomes in medically assisted reproduction (MAR): a case control study
C. Siristatidis, Viktoria Christoforaki, Z. Zafeiriou, G. Mastorakos +2 more
2019Gynecological Endocrinology5 citations
Semantic Scholar
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 in patients with mCRPC.
M. Kolinsky, P. Rescigno, D. Bianchini, Z. Zafeiriou +16 more
20175 citations
Semantic Scholar
Association between PSA declines at 4 weeks and OS in patients treated with abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC) after docetaxel.
P. Rescigno, D. Lorente, R. Ferraldeschi, D. Bianchini +15 more
20155 citations
Semantic Scholar
Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents
Z. Zafeiriou, A. Jayaram, A. Sharp, J. de Bono
2016Drugs4 citations
Semantic Scholar
Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)
Michael Liontos, E. Timotheadou, Emmanuel I. Papadopoulos, Z. Zafeiriou +9 more
2021Current Oncology3 citations Open access
Semantic Scholar
Abstract 4679: Mismatch repair defects in lethal prostate cancer
P. Rescigno, D. Rodrigues, W. Yuan, S. Carreira +18 more
20173 citations
Semantic Scholar
Abstract 993: Diagnostic leukapheresis (DLA): Molecular characterisation and organoid culture of circulating tumor cells (CTC) from metastatic castration resistant prostate cancer (mCRPC)
M. Lambros, V. Gil, M. Crespo, M. Fontes +22 more
20173 citations
Semantic Scholar
Clinical characteristics of metastatic castration-resistant prostate cancer (mCRPC) patients with DNA repair (DNAr) defects.
M. Kolinsky, J. Mateo, S. Sumanasuriya, P. Rescigno +13 more
20163 citations
Semantic Scholar
791PSEQUENCING OF DOCETAXEL (D) AND ABIRATERONE ACETATE (AA) FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC).
Z. Zafeiriou, R. Ferraldeschi, Aurelius Omlin, C. Pezaro +15 more
2014Annals of Oncology3 citations Open access
Semantic Scholar
Association of changes in circulating cell-free plasma DNA (cfDNA) and circulating tumor cells (CTC) during treatment with clinical outcome from olaparib in castration-resistant prostate cancer (CRPC): Exploratory analyses from the TOPARP-A trial.
J. Mateo, H. Mossop, J. Goodall, D. Lorente +16 more
20172 citations
Semantic Scholar
Abiraterone for the Treatment of mCRPC
Z. Zafeiriou, N. Mehra, J. de Bono
20162 citations
Semantic Scholar
Phase 1-2 study of progesterone receptor (PR) inhibition with extended-release (ER) onapristone (ONA) in patients (pts) with castration-resistant prostate cancer (CRPC): PK, safety and PR testing results from the dose escalation cohort.
A. Jayaram, K. Nowakowska, J. Mateo, D. Rodrigues +11 more
20152 citations
Semantic Scholar
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
F. Koinis, A. Polyzos, A. Christopoulou, Z. Zafeiriou +6 more
2014Cancer Chemotherapy and Pharmacology2 citations
Semantic Scholar
Detection of ESR1 and PIK3CA actionable mutations in breast cancer using liquid biopsy: A step toward precision medicine.
A. Christopoulou, M. Vlachou, S. Karageorgopoulou, Flora Zagouri +16 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. de Bono×39
Invite
J. de Bono — researcher profile on SciRah
J. Mateo×29
Invite
J. Mateo — researcher profile on SciRah
D. Bianchini×27
Invite
D. Bianchini — researcher profile on SciRah
N. Tunariu×23
Invite
N. Tunariu — researcher profile on SciRah

×21

Invite

P. Rescigno — researcher profile on SciRah

Invite

S. Miranda — researcher profile on SciRah

R. Riisnaes×17

Invite

R. Riisnaes — researcher profile on SciRah

R. Ferraldeschi×16

Invite

R. Ferraldeschi — researcher profile on SciRah

S. Carreira×16

Invite

S. Carreira — researcher profile on SciRah

I. Figueiredo×15

Invite

I. Figueiredo — researcher profile on SciRah

Invite

G. Attard — researcher profile on SciRah

Invite

P. Flohr — researcher profile on SciRah